Company intelligence / Profile preview

HCmed Innovations

Da'an District, Taipei City, Taiwanhcmed-inno.com ↗

Ownership: Private
Development stage: Other

Overview

HCmed Innovations provides a customizable vibrating mesh nebulizer platform as a CDMO partner to pharmaceutical companies. Their devices are approved in several international markets and support the efficient delivery of both small molecule and biologic inhaled therapies. The company enables pharma partners to develop drug-device combination products from feasibility through commercialization. No proprietary clinical-stage drugs; clinical results pertain to device performance and regulatory approvals.

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: DeviceBiologicSmall molecule
Industry: Therapeutic Medical Devices

Partnerships

Undisclosed global pharmaceutical companies

Beyond the preview

Go deeper on HCmed Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HCmed Innovations.

Explore the full profile